NCT04947995View on ClinicalTrials.gov

Multi-Omics Noninvasive Inspection of TumOr Risk for Gastric Cancer

UnknownOBSERVATIONAL
Enrollment

450

Participants

Timeline

Start Date

June 15, 2021

Primary Completion Date

June 15, 2023

Study Completion Date

June 15, 2023

Conditions
Gastric Cancer
Interventions
DEVICE

ctDNA multi-omics test

The ctDNA multi-omics test for gastric cancer will be built based on low-pass WGS, methylation, and target region sequencing.

Trial Locations (1)

100021

RECRUITING

Cancer Hospital, Chinese Academy of Medical Sciences, Beijing

Sponsors
All Listed Sponsors
collaborator

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

OTHER

lead

GeneCast Biotechnology Co., Ltd.

INDUSTRY

NCT04947995 - Multi-Omics Noninvasive Inspection of TumOr Risk for Gastric Cancer | Biotech Hunter | Biotech Hunter